1. Home
  2. MDGL vs VOYA Comparison

MDGL vs VOYA Comparison

Compare MDGL & VOYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • VOYA
  • Stock Information
  • Founded
  • MDGL 2011
  • VOYA 1975
  • Country
  • MDGL United States
  • VOYA United States
  • Employees
  • MDGL N/A
  • VOYA N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • VOYA Life Insurance
  • Sector
  • MDGL Health Care
  • VOYA Finance
  • Exchange
  • MDGL Nasdaq
  • VOYA Nasdaq
  • Market Cap
  • MDGL 6.8B
  • VOYA 6.8B
  • IPO Year
  • MDGL N/A
  • VOYA 2013
  • Fundamental
  • Price
  • MDGL $290.96
  • VOYA $69.53
  • Analyst Decision
  • MDGL Strong Buy
  • VOYA Buy
  • Analyst Count
  • MDGL 10
  • VOYA 13
  • Target Price
  • MDGL $420.63
  • VOYA $80.67
  • AVG Volume (30 Days)
  • MDGL 361.7K
  • VOYA 992.4K
  • Earning Date
  • MDGL 05-01-2025
  • VOYA 05-06-2025
  • Dividend Yield
  • MDGL N/A
  • VOYA 2.58%
  • EPS Growth
  • MDGL N/A
  • VOYA N/A
  • EPS
  • MDGL N/A
  • VOYA 5.32
  • Revenue
  • MDGL $317,383,000.00
  • VOYA $7,968,000,000.00
  • Revenue This Year
  • MDGL $264.55
  • VOYA N/A
  • Revenue Next Year
  • MDGL $67.21
  • VOYA $5.24
  • P/E Ratio
  • MDGL N/A
  • VOYA $13.09
  • Revenue Growth
  • MDGL N/A
  • VOYA 5.34
  • 52 Week Low
  • MDGL $200.08
  • VOYA $52.43
  • 52 Week High
  • MDGL $377.46
  • VOYA $84.30
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.85
  • VOYA 67.58
  • Support Level
  • MDGL $280.00
  • VOYA $68.10
  • Resistance Level
  • MDGL $307.54
  • VOYA $71.03
  • Average True Range (ATR)
  • MDGL 15.97
  • VOYA 1.43
  • MACD
  • MDGL -2.00
  • VOYA 1.16
  • Stochastic Oscillator
  • MDGL 15.88
  • VOYA 88.71

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About VOYA Voya Financial Inc.

Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.

Share on Social Networks: